Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Borro

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Panminerva Medica|September 25, 2009
Pegylated interferon alfa-2a and ribavirin treatment for recurrent hepatitis C: role of steatosis and body mass indexG Testino, R Gentile, F Ansaldi, et al.
Alimentary Pharmacology & Therapeutics|May 3, 2000
Comparative effects of levosulpiride and cisapride on gastric emptying and symptoms in patients with functional dyspepsia and gastroparesisC Mansi, P Borro, M Giacomini, et al.
Hepato-Gastroenterology|December 2, 2000
Does surveillance for hepatocellular carcinoma in HCV cirrhotic patients improve treatment outcome mainly due to better clinical status at diagnosis?E Giannini, L Arzani, P Borro, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 6, 2005
Application of the platelet count/spleen diameter ratio to rule out the presence of oesophageal varices in patients with cirrhosis: a validation study based on follow-upE G Giannini, F Botta, P Borro, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|August 1, 1995
Serum lipid levels during interferon therapy in patients with chronic hepatitis CA Picciotto, S Bertolini, E Bardellini, et al.
Journal of Internal Medicine|August 3, 2006
Noninvasive ratio indexes to evaluate fibrosis staging in chronic hepatitis C: role of platelet count/spleen diameter ratio indexR Testa, E Testa, E Giannini, et al.
European Journal of Gastroenterology & Hepatology|July 1, 1995
Detection of anti-HCV IgM antibodies in patients with chronic hepatitis C treated with interferonA Picciotto, G Icardi, E Bardellini, et al.
Gut|July 17, 2003
Platelet count/spleen diameter ratio: proposal and validation of a non-invasive parameter to predict the presence of oesophageal varices in patients with liver cirrhosisE Giannini, F Botta, P Borro, et al.
Alimentary Pharmacology & Therapeutics|December 12, 2001
Impairment of cytochrome P-450-dependent liver activity in cirrhotic patients with Helicobacter pylori infectionE Giannini, A Fasoli, P Borro, et al.
Alimentary Pharmacology & Therapeutics|September 25, 2002
Stool antigen assay (HpSA) is less reliable than urea breath test for post-treatment diagnosis of Helicobacter pylori infectionC Bilardi, R Biagini, P Dulbecco, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Panminerva Medica|September 25, 2009
Pegylated interferon alfa-2a and ribavirin treatment for recurrent hepatitis C: role of steatosis and body mass indexG Testino, R Gentile, F Ansaldi, et al.
Alimentary Pharmacology & Therapeutics|May 3, 2000
Comparative effects of levosulpiride and cisapride on gastric emptying and symptoms in patients with functional dyspepsia and gastroparesisC Mansi, P Borro, M Giacomini, et al.
Hepato-Gastroenterology|December 2, 2000
Does surveillance for hepatocellular carcinoma in HCV cirrhotic patients improve treatment outcome mainly due to better clinical status at diagnosis?E Giannini, L Arzani, P Borro, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 6, 2005
Application of the platelet count/spleen diameter ratio to rule out the presence of oesophageal varices in patients with cirrhosis: a validation study based on follow-upE G Giannini, F Botta, P Borro, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|August 1, 1995
Serum lipid levels during interferon therapy in patients with chronic hepatitis CA Picciotto, S Bertolini, E Bardellini, et al.
Journal of Internal Medicine|August 3, 2006
Noninvasive ratio indexes to evaluate fibrosis staging in chronic hepatitis C: role of platelet count/spleen diameter ratio indexR Testa, E Testa, E Giannini, et al.
European Journal of Gastroenterology & Hepatology|July 1, 1995
Detection of anti-HCV IgM antibodies in patients with chronic hepatitis C treated with interferonA Picciotto, G Icardi, E Bardellini, et al.
Gut|July 17, 2003
Platelet count/spleen diameter ratio: proposal and validation of a non-invasive parameter to predict the presence of oesophageal varices in patients with liver cirrhosisE Giannini, F Botta, P Borro, et al.
Alimentary Pharmacology & Therapeutics|December 12, 2001
Impairment of cytochrome P-450-dependent liver activity in cirrhotic patients with Helicobacter pylori infectionE Giannini, A Fasoli, P Borro, et al.
Alimentary Pharmacology & Therapeutics|September 25, 2002
Stool antigen assay (HpSA) is less reliable than urea breath test for post-treatment diagnosis of Helicobacter pylori infectionC Bilardi, R Biagini, P Dulbecco, et al.
Pageof 3